• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻内和皮内感染后的差异免疫反应及其对疫苗开发的影响。

Differential Immune Response Following Intranasal and Intradermal Infection with Implications for Vaccine Development.

作者信息

Nicol McKayla J, Williamson David R, Place David E, Kirimanjeswara Girish S

机构信息

Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802, USA.

Pathobiology Graduate Program, The Pennsylvania State University, University Park, PA 16802, USA.

出版信息

Microorganisms. 2021 Apr 30;9(5):973. doi: 10.3390/microorganisms9050973.

DOI:10.3390/microorganisms9050973
PMID:33946283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8145380/
Abstract

( is a Gram-negative, facultative intracellular coccobacillus that is the etiological agent of tularemia. Interestingly, the disease tularemia has variable clinical presentations that are dependent upon the route of infection with . Two of the most likely routes of infection include intranasal and intradermal, which result in pneumonic and ulceroglandular tularemia, respectively. While there are several differences between these two forms of tularemia, the most notable disparity is between mortality rates: the mortality rate following pneumonic tularemia is over ten times that of the ulceroglandular disease. Understanding the differences between intradermal and intranasal infections is important not only for clinical diagnoses and treatment but also for the development of a safe and effective vaccine. However, the immune correlates of protection against , especially within the context of infection by disparate routes, are not yet fully understood. Recent advances in different animal models have revealed new insights in the complex interplay of innate and adaptive immune responses, indicating dissimilar patterns in both responses following infection with via different routes. Further investigation of these differences will be crucial to predicting disease outcomes and inducing protective immunity via vaccination or natural infection.

摘要

(是一种革兰氏阴性兼性胞内球杆菌,是兔热病的病原体。有趣的是,兔热病有多种临床表现,这取决于感染途径。两种最常见的感染途径包括经鼻和经皮,分别导致肺型兔热病和溃疡腺型兔热病。虽然这两种兔热病形式之间存在一些差异,但最显著的差异在于死亡率:肺型兔热病后的死亡率是溃疡腺型疾病的十倍以上。了解经皮和经鼻感染之间的差异不仅对临床诊断和治疗很重要,而且对开发安全有效的疫苗也很重要。然而,针对的保护性免疫相关因素,特别是在不同途径感染的情况下,尚未完全了解。不同动物模型的最新进展揭示了先天免疫和适应性免疫反应复杂相互作用的新见解,表明通过不同途径感染后两种反应的模式不同。进一步研究这些差异对于预测疾病结果以及通过疫苗接种或自然感染诱导保护性免疫至关重要。 )

需要说明的是,原文中存在一处表述不完整(“( is a Gram-negative”括号里缺少具体菌名),以上译文是基于现有内容尽量完整准确翻译的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4719/8145380/8af28f4ca15a/microorganisms-09-00973-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4719/8145380/8af28f4ca15a/microorganisms-09-00973-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4719/8145380/8af28f4ca15a/microorganisms-09-00973-g001.jpg

相似文献

1
Differential Immune Response Following Intranasal and Intradermal Infection with Implications for Vaccine Development.鼻内和皮内感染后的差异免疫反应及其对疫苗开发的影响。
Microorganisms. 2021 Apr 30;9(5):973. doi: 10.3390/microorganisms9050973.
2
GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.GM-CSF 在鼻内和皮内感染土拉弗朗西斯菌中具有不同的作用。
Microbes Infect. 2016 Dec;18(12):758-767. doi: 10.1016/j.micinf.2016.07.003. Epub 2016 Jul 27.
3
Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain.目的 2 和 Nlrp3 对于对抗弗朗西斯氏菌活疫苗株的疫苗诱导免疫是可有可无的。
Infect Immun. 2021 Jun 16;89(7):e0013421. doi: 10.1128/IAI.00134-21.
4
Contributions of TolC Orthologs to Schu S4 Multidrug Resistance, Modulation of Host Cell Responses, and Virulence.托尔克(TolC)同源物对施氏假单胞菌 S4 多药耐药性、宿主细胞反应调节和毒力的贡献。
Infect Immun. 2019 Mar 25;87(4). doi: 10.1128/IAI.00823-18. Print 2019 Apr.
5
Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.鼻腔内给予两剂佐剂多抗原 TMV-亚单位缀合疫苗可完全保护小鼠免受兔热病杆菌 LVS 挑战。
PLoS One. 2018 Apr 23;13(4):e0194614. doi: 10.1371/journal.pone.0194614. eCollection 2018.
6
A galU mutant of Francisella tularensis is attenuated for virulence in a murine pulmonary model of tularemia.弗氏志贺菌的 galU 突变体能减弱在感染性肺炎的鼠模型中的毒力。
BMC Microbiol. 2011 Aug 5;11:179. doi: 10.1186/1471-2180-11-179.
7
Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.鼻内接种可诱导针对强毒土拉弗朗西斯菌生物变种A鼻内感染的保护性免疫。
Infect Immun. 2005 May;73(5):2644-54. doi: 10.1128/IAI.73.5.2644-2654.2005.
8
Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.接种疫苗的小鼠对肺鼠疫的保护与肺部早期记忆哨位反应有关。
Vaccine. 2017 Dec 15;35(50):7001-7009. doi: 10.1016/j.vaccine.2017.10.053. Epub 2017 Nov 6.
9
Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.土拉热弗朗西斯菌活疫苗株感染的免疫后果:天然免疫反应在感染和免疫中的作用
J Immunol. 2006 Jun 1;176(11):6888-99. doi: 10.4049/jimmunol.176.11.6888.
10
Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.鉴定土拉弗朗西斯菌外膜蛋白 A(FopA)作为土拉菌病的保护性抗原。
Vaccine. 2011 Sep 16;29(40):6941-7. doi: 10.1016/j.vaccine.2011.07.075. Epub 2011 Jul 29.

引用本文的文献

1
The immune response to .对……的免疫反应。 (你提供的原文不完整,以上是根据现有内容翻译的)
Front Microbiol. 2025 Apr 25;16:1549343. doi: 10.3389/fmicb.2025.1549343. eCollection 2025.
2
Protective potential of outer membrane vesicles derived from a virulent strain of .源自. 强毒株的外膜囊泡的保护潜力
Front Microbiol. 2024 Mar 12;15:1355872. doi: 10.3389/fmicb.2024.1355872. eCollection 2024.
3
Pathogenicity and virulence of . 的致病性和毒力。

本文引用的文献

1
Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.气溶胶初免-加强免疫接种可在外群兔中提供针对强毒A型土拉弗朗西斯菌的强大保护。
PLoS One. 2018 Oct 22;13(10):e0205928. doi: 10.1371/journal.pone.0205928. eCollection 2018.
2
Adaptive Immunity to and Considerations for Vaccine Development.适应性免疫与疫苗开发的考虑因素。
Front Cell Infect Microbiol. 2018 Apr 6;8:115. doi: 10.3389/fcimb.2018.00115. eCollection 2018.
3
Development of a novel Francisella tularensis Live Vaccine Strain expressing ovalbumin provides insight into antigen-specific CD8+ T cell responses.
Virulence. 2023 Dec;14(1):2274638. doi: 10.1080/21505594.2023.2274638. Epub 2023 Nov 8.
4
and immune responses against vaccines are comparable among Fischer 344 rat substrains.费希尔344大鼠亚系对疫苗的免疫反应具有可比性。
Front Microbiol. 2023 Jul 13;14:1224480. doi: 10.3389/fmicb.2023.1224480. eCollection 2023.
5
Comparative evaluation of protective immunity against induced by subunit or adenovirus-vectored vaccines.诱导的保护性免疫的亚单位疫苗或腺病毒载体疫苗的比较评价。
Front Cell Infect Microbiol. 2023 May 25;13:1195314. doi: 10.3389/fcimb.2023.1195314. eCollection 2023.
表达卵清蛋白的新型土拉弗朗西斯菌活疫苗株的开发为抗原特异性CD8 + T细胞反应提供了见解。
PLoS One. 2017 Dec 28;12(12):e0190384. doi: 10.1371/journal.pone.0190384. eCollection 2017.
4
The Natural History of Pneumonic Tularemia in Female Fischer 344 Rats after Inhalational Exposure to Aerosolized Francisella tularensis Subspecies tularensis Strain SCHU S4.雌性Fischer 344大鼠经吸入雾化的土拉弗朗西斯菌土拉亚种菌株SCHU S4后肺型兔热病的自然病史。
Am J Pathol. 2017 Feb;187(2):252-267. doi: 10.1016/j.ajpath.2016.09.021. Epub 2016 Dec 8.
5
Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.呼吸道和口服疫苗接种可增强活疫苗株对兔模型肺鼠疫的保护作用。
Pathog Dis. 2016 Oct;74(7). doi: 10.1093/femspd/ftw079. Epub 2016 Aug 9.
6
GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.GM-CSF 在鼻内和皮内感染土拉弗朗西斯菌中具有不同的作用。
Microbes Infect. 2016 Dec;18(12):758-767. doi: 10.1016/j.micinf.2016.07.003. Epub 2016 Jul 27.
7
Tularaemia: clinical aspects in Europe.兔热病:欧洲的临床方面。
Lancet Infect Dis. 2016 Jan;16(1):113-124. doi: 10.1016/S1473-3099(15)00355-2.
8
Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection.采用TgPI-1的同源初免-加强策略可改善免疫反应,并保护高度易感小鼠免受慢性弓形虫感染。
Acta Trop. 2015 Oct;150:159-65. doi: 10.1016/j.actatropica.2015.07.013. Epub 2015 Jul 19.
9
Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments.黏膜免疫与新型结核病疫苗策略:免疫途径决定T细胞归巢至受限的肺黏膜区室
Eur Respir Rev. 2015 Jun;24(136):356-60. doi: 10.1183/16000617.00002515.
10
Perforin and granzymes: function, dysfunction and human pathology.穿孔素和颗粒酶:功能、功能障碍与人类病理学。
Nat Rev Immunol. 2015 Jun;15(6):388-400. doi: 10.1038/nri3839.